Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Molecular Biology of the Cell|October 5, 2012
RhoD activated by fibroblast growth factor induces cytoneme-like cellular protrusions through mDia3CKazuhisa Koizumi, Kazunori Takano, Akiko Kaneyasu, et al.BMC Cancer|July 31, 2014
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancerYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2024
Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitorsKeishiro Izumi, Tomokazu Iyoda, Atsuko Yokota, et al.Cancer Diagnosis & Prognosis|November 6, 2023
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast CancerYumiko Ishizuka, Yoshiya Horimoto, Midori Morita, et al.Medical Oncology (Northwood, London, England)|September 15, 2019
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancerMayuko Ito, Yoshiya Horimoto, Emi Tokuda, et al.Cancer Research|October 19, 2007
Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivoEmi Tokuda, Naoya Fujita, Tomoko Oh-hara, et al.Breast Cancer (Tokyo, Japan)|January 15, 2022
Is adjuvant chemotherapy necessary in older patients with breast cancer?Midori Morita, Akihiko Shimomura, Emi Tokuda, et al.Journal of Translational Medicine|October 22, 2018
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot studyYoshiya Horimoto, Emi Tokuda, Fumi Murakami, et al.Journal of Clinical Pathology|June 11, 2015
Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patientsYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.Cancers|January 21, 2023
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast CancerYutaka Natori, Junko Suga, Emi Tokuda, et al.Pageof 4